IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 401 - 420 of 1047 stories.
April 26, 2012
DSM and Crucell (Leiden, the Netherlands), a biotech firm, have pulled the plug on all inhouse projects at their biosimilar drugs joint venture company Percivia (Cambridge, MA). Set up...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmaceuticals-DSM-Joint-Venture-Percivia-Ceases-Inhouse-Activities_43001.html
April 26, 2012
Watson Pharmaceuticals (Parsippany, NJ), a leading manufacturer of generic, branded and biologic pharmaceutical products, and privately held generic pharmaceuticals company Actavis...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Watson-Pharmaceuticals-to-Acquire-Actavis-for-$5-6-Billion_43002.html
April 25, 2012
Codexis (Redwood City, CA) says that the U.S. FDA has approved a new process co-developed by Codexis for the manufacture of sitagliptin, the active pharmaceutical ingredient (API) in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-Approves-Process-Co-Developed-by-Codexis-to-Produce-Sitagliptin-API_42957.html
April 24, 2012
FDA STRENGTHENS INTERNATIONAL COLLABORATION TO ENSURE SAFETY OF IMPORTED PHARMA PRODUCTS The U.S. Food and Drug Administration (FDA) says it is taking several steps to ensure that...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-April-24_42924.html
April 24, 2012
The U.S. Food and Drug Administration (FDA) says it is taking several steps to ensure that imported drugs meet the same rigorous standards for safety and quality as those manufactured...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-Strengthens-International-Collaboration-to-ensure-Safety-of-Imported-Products_42923.html
April 24, 2012
W. R. Grace, in partnership with Formac Pharmaceuticals (Heverlee, Belgium), announced positive data from initial human studies of the companies' mesoporous silica-based drug delivery...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Grace-and-Formac-Announce-Positive-Data-from-Clinical-Trial-Demonstrating-Use-of-Silica-for-Drug-Delivery_42919.html
April 23, 2012
Pfizer says it has entered into an agreement to divest its nutrition business to Nestlé (Vevey, Switzerland) for $11.85 billion in cash. Pfizer’s nutrition business...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Nestle-to-Acquire-Pfizers-Nutrition-Business-for-$11-85-Billion_42887.html
April 23, 2012
The Chinese government says that the Ministry of Public Security (Beijing) has confiscated 77 million capsules made from toxic chromium-contained industrial gelatin. Earlier this...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Police-Confiscate-77-Million-Contaminated-Capsules-in-China_42891.html
April 19, 2012
Mylan (Canonsburg, PA) says it will invest €76 million/year ($100 million/year) over the next five years in the company’s operations at Dublin and Galway in Ireland. Mylan...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mylan-to-Invest-$500-Million-in-Ireland-Over-Next-Five-Years_42788.html
April 19, 2012
The answer to the question of whether there could be a revolution to bring about Quality by Design (QbD) in pharmaceutical manufacturing, unequivocally, is yes. But we need some...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Can-the-Combination-of-Creative-Destruction-and-Steve-Jobs-Traits-Lead-to-a-Pharma-QbD-Spring_42714.html
April 17, 2012
AMRI SIGNS DEVELOPMENT AND MANUFACTURING DEAL WITH AUSTRALIAN FIRM Albany Molecular Research Inc. (AMRI; Albany, NY) says it was selected by Biota (Melbourne Australia), a leading...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-April-17_42724.html
April 17, 2012
Omkar Speciality Chemicals (Thane, India) says it has entered the pharmaceutical ingredients business with the acquisition of LASA Laboratory (Raigad, India). LASA is an established...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Omkar-Speciality-Chemicals-Enters-API-Business_42723.html
April 17, 2012
Albany Molecular Research Inc. (AMRI; Albany, NY) says it was selected by Biota (Melbourne Australia), a leading anti-infective drug development company, to further develop and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/AMRI-Signs-Development-and-Manufacturing-Deal-with-Australian-Firm_42719.html
April 17, 2012
The Chinese government says that the State Food and Drug Administration (SFDA; Beijing) has issued a notice to suspend the selling and consumption of a list of capsules with reported...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/China-Issues-Alert-Against-Chromium-Contaminated-Capsules_42711.html
April 16, 2012
BASF has launched a new series of fine chemical excipients with enhanced solubility, as well as excipients with enhanced properties for medical creams applied to the skin. The new...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/BASF-Expands-Renames-Fine-Chemical-Excipients-Range_42640.html
April 12, 2012
Lonza this week disclosed that it has signed a contract to supply biotech firm Agennix (Heidelberg, Germany) with commercial quantities of Agennix's talactoferrin trial biopharma drug...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Fine-Chemicals-Weekly-News-Round-up-April-12_42642.html
April 12, 2012
Lonza has agreed to supply Agennix (Heidelberg, Germany), a biotech firm, with commercial quantities of talactoferrin, Agennix’s trial drug for the treatment of non-small cell...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-Joins-DSM-as-Manufacturer-of-Biopharma-Drug-for-Agennix_42641.html
April 11, 2012
Private equity firm SK Capital (New York) and Ion Beam Applications (IBA; Lorain-la-Nueve, Belgium), a medical device company, have formed a jointly-owned distributor of radioactive...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/SK-Capital-IBA-Form-Medical-Isotopes-Distributor_42630.html
April 5, 2012
Sigma-Aldrich says it has acquired all outstanding shares of Research Organics (Cleveland, OH), to expand the company’s buffer production capacity and to increase its portfolio...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sigma-Aldrich-Acquires-Research-Organics-to-Strengthen-Portfolio-of-Pharmaceutical-Grade-Raw-Materials_42507.html
April 5, 2012
BASF says it has entered into a broad collaboration and open alliance with Catalent Pharma Solutions (Somerset, NJ), to provide solutions to overcome bioavailability challenges of new...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/BASF-and-Catalent-Team-up-to-Solve-Bioavailability-Challenges_42506.html
Pages: « Previous  12 13 14 15 16 17 18 19 20 [21] 22 23 24 25 26 27 28 29 30 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa